Sleep-inducing effects mediated by a selective orexin-2 receptor antagonist during the light phase in the rat

被引：0
|
作者：
Shelton, J. [1 ]
Sutton, S. [1 ]
Yun, S. [1 ]
Li, S. [1 ]
Dvorak, C. [1 ]
Carruthers, N. [1 ]
Lovenberg, T. [1 ]
Dugovic, C. [1 ]
机构：
[1] Johnson & Johnson PRDUS LLC, San Diego, CA USA
来源：
JOURNAL OF SLEEP RESEARCH | 2008年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：201 / 201
页数：1
相关论文
共 50 条
  • [1] Sleep-inducing effects mediated by selective blockade of orexin OX2 receptors during the light phase in the rat
    Dugovic, C.
    Shelton, J.
    Sutton, S.
    Yun, S.
    Li, X.
    Dvorak, C.
    Carruthers, N.
    Atack, J.
    Lovenberg, T.
    SLEEP, 2008, 31 : A33 - A33
  • [2] Intracerebroventricular injection of orexin-2 receptor antagonist promotes REM sleep
    Kummangal, Basheer Ahamad
    Kumar, Deependra
    Mallick, Hruda Nanda
    BEHAVIOURAL BRAIN RESEARCH, 2013, 237 : 59 - 62
  • [3] Effects of the selective orexin-2 receptor antagonist JNJ-48816274 on sleep initiated in the circadian wake maintenance zone: a randomised trial
    Victoria L. Revell
    Ciro della Monica
    Jeewaka Mendis
    Hana Hassanin
    Robin J. Halter
    Sandra R. Chaplan
    Derk-Jan Dijk
    Neuropsychopharmacology, 2022, 47 : 719 - 727
  • [4] Effects of a newly developed potent orexin-2 receptor-selective antagonist, compound 1 m, on sleep/wakefulness states in mice
    Etori, Keishi
    Saito, Yuki C.
    Tsujino, Natsuko
    Sakurai, Takeshi
    FRONTIERS IN NEUROSCIENCE, 2014, 8
  • [5] Effects of the selective orexin-2 receptor antagonist JNJ-48816274 on sleep initiated in the circadian wake maintenance zone: a randomised trial
    Revell, Victoria L.
    della Monica, Ciro
    Mendis, Jeewaka
    Hassanin, Hana
    Halter, Robin J.
    Chaplan, Sandra R.
    Dijk, Derk-Jan
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (03) : 719 - 727
  • [6] Identification of MK-8133: An orexin-2 selective receptor antagonist with favorable development properties
    Kuduk, Scott D.
    Skudlarek, Jason W.
    DiMarco, Christina N.
    Bruno, Joseph G.
    Pausch, Mark H.
    O'Brien, Julie A.
    Cabalu, Tamara D.
    Stevens, Joanne
    Brunner, Joseph
    Tannenbaum, Pamela L.
    Garson, Susan L.
    Savitz, Alan T.
    Harrell, Charles M.
    Gotter, Anthony L.
    Winrow, Christopher J.
    Renger, John J.
    Coleman, Paul J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (12) : 2488 - 2492
  • [7] Effects of an Orexin-2 Receptor Antagonist on Sleep and Event-Related Oscillations in Female Rats Exposed to Chronic Intermittent Ethanol During Adolescence
    Amodeo, Leslie R.
    Wills, Derek N.
    Sanchez-Alavez, Manuel
    Ehlers, Cindy L.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2020, 44 (07): : 1378 - 1388
  • [8] BLOCKADE OF OREXIN-I RECEPTORS ATTENUATES OREXIN-2 RECEPTOR ANTAGONISM INDUCED SLEEP PROMOTION IN THE RAT
    Dugovic, C.
    Shelton, J.
    Aluisio, L.
    Fraser, I
    Sutton, S.
    Pascal, B.
    Yun, S.
    Li, X.
    Dvorak, C.
    Lovenberg, T.
    SLEEP, 2009, 32 : A1 - A1
  • [9] Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia
    Bonaventure, Pascal
    Shelton, Jonathan
    Yun, Sujin
    Nepomuceno, Diane
    Sutton, Steven
    Aluisio, Leah
    Fraser, Ian
    Lord, Brian
    Shoblock, James
    Welty, Natalie
    Chaplan, Sandra R.
    Aguilar, Zuleima
    Halter, Robin
    Ndifor, Anthony
    Koudriakova, Tatiana
    Rizzolio, Michele
    Letavic, Michael
    Carruthers, Nicholas I.
    Lovenberg, Timothy
    Dugovic, Christine
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2015, 354 (03): : 471 - 482
  • [10] Blockade of Orexin-1 Receptors Attenuates Orexin-2 Receptor Antagonism-Induced Sleep Promotion in the Rat
    Dugovic, Christine
    Shelton, Jonathan E.
    Aluisio, Leah E.
    Fraser, Ian C.
    Jiang, Xiaohui
    Sutton, Steven W.
    Bonaventure, Pascal
    Yun, Sujin
    Li, Xiaorong
    Lord, Brian
    Dvorak, Curt A.
    Carruthers, Nicholas I.
    Lovenberg, Timothy W.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 330 (01): : 142 - 151
12345